Pinned post
We are hiring postdocs. If you are passionate about using iPSC, CRISPR screens, organoids, and multiomics to understand cardiovascular disease and advance precision medicine.
@twinsmc18
Pinned post
Grateful for the support from @Joseph_C_Wu, @stanleyqilab, all the amazing collaborators @twinsmc18. Also my current department @MCWPhysiology and centers @MCWCancerCenter @CVCatMCW for their ongoing support, enabling us to expand this work to other CVDs and perturb-seq platformView quoted post on X
Results from AI-Designed Drug ISM001-055 in Treating Pulmonary FibrosisView quoted post on X
A novel drug named ISM001-055 has shown positive outcomes in clinical trials aimed at treating Idiopathic Pulmonary Fibrosis (IPF).
Developed by Insilico Medicine using generative #AI, the drug targets a specific protein associated with lung fibrosis.
In a Phase IIa trial involving 71 patients, ISM001-055 demonstrated safety and a dose-dependent improvement in lung function, particularly in patients receiving a daily dosage of 60mg.
The drug’s design process exemplifies the application of AI in identifying new therapeutic targets and designing treatment options, indicating potential for future use in other fibrotic conditions as well.
AI in Healthcare #GenAI #TechBio #HealthAI #MedTwitter #MedicalAI